Johnny Vercouillie - Concepedia

Author

Johnny Vercouillie

Also Known As

Federico E. Turkheimer, J. Vercouillie, Johnny VERCOUILLIE, Johnny Vercouillie, Johny Vercouillie, Pin, Frederic, Siluval Raju Mary Jony, Vercouillie Johnny, Vercouillie, Johnny

113

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Inserm Université de Tours Centre Hospitalier Universitaire de Tours Clinical Investigation Center Plurithematic Tours Centre National de la Recherche Scientifique

About

Johnny Vercouillie is an author at Inserm specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	524
2	Natural Sciences	3	3	43
3	Social Sciences	3	3	81
4	Engineering	2	2	30
5	Health Sciences	1	1	64

Johnny Vercouillie

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment Vincent Camus, Pierre Payoux, Louisa Barré, European Journal of Nuclear Medicine and Molecular Imaging	2012	247
Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation Nicolas Arlicot, Johnny Vercouillie, Maria-Joao Santiago Ribeiro, Nuclear Medicine and Biology Neuroimaging BiomarkersAlzheimer's DiseaseInitial EvaluationMedicineBiomarkers	2011	130
Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: MRI and<sup>18</sup>F-FDG PET Quantitative Analysis Using FreeSurfer Matthieu Bailly, Christophe Destrieux, Caroline Hommet, BioMed Research International	2015	120
Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study Aisling M. Chaney, Francisco R. Lopez‐Picon, Sophie Sérrière, Theranostics	2021	77
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality Gert Luurtsema, Verena Pichler, Salvatore Bongarzone, EJNMMI Radiopharmacy and Chemistry	2021	75
Carbon‐11 labelling of madam in two different positions: A highly selective pet radioligand for the serotonin transporter Jari Tarkiainen, Johnny Vercouillie, Denis Guilloteau, Journal of Labelled Compounds and Radiopharmaceuticals Selective Pet RadioligandBiochemistryMedicinePhysiologyNeuropharmacology	2001	69
[11C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET Christer Halldin, Johan Lundberg, Judit Sóvágó, Synapse	2005	66
Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state Alessandro Villa, Barbara Klein, Bieneke Janssen, Theranostics	2018	65
Carbon‐11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter Jari Tarkiainen, Johnny Vercouillie, Patrick Emond, Journal of Labelled Compounds and Radiopharmaceuticals Psychotropic MedicationPositron Emission TomographyMolecular PharmacologySelective Pet RadioligandRadiopharmaceutical Therapy	2001	64
Pharmacological Characterization of N,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity Sylvie Chalon, Jari Tarkiainen, Lucette Garreau, Journal of Pharmacology and Experimental Therapeutics	2003	55

Page 1